Literature DB >> 2475155

Alpha-fetoprotein (AFP) in granulomatous inflammation of the mouse.

J Trojan1, J Naval, H Jusforgues, J Uriel.   

Abstract

Inflammatory granulomas constituted of various proportions of macrophages, polynuclear (PMNs) and mononuclear cells were induced in adult pathogen-free mice by injecting polyacrylamide beads into subcutaneous pouches. Using specific anti-mouse alpha-fetoprotein (AFP) antibodies, the presence of AFP was immunocytochemically demonstrated in the cytoplasm of macrophages and of immature PMNs (mature PMNs and mononuclear cells were AFP negative). AFP-labelling started as soon as 36 h after granuloma induction and reached a maximum 60-72 h later, to disappear on day 5. The examination of different organs in these mice also showed a transitory labelling for AFP of liver hepatocytes and of elements of kidney and of exocrine pancreas. Parallel to these findings, the selective concentration inside the granulomatous pouches of radiolabelled AFP injected in the course of inflammation was observed. These results suggest that (a) shortly after the inflammatory reaction the synthesis of AFP is resumed by the liver; (b) the newly synthesized AFP is secreted in the serum and preferentially taken up by the granulomas; and (c) consequently, in adult mice, AFP behaves as a positive acute phase reactant. The physiopathological implications of these facts are discussed in relation with the biological properties of AFP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475155      PMCID: PMC2040556     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  14 in total

1.  Transcriptional regulation of plasma protein synthesis during inflammation.

Authors:  H E Birch; G Schreiber
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

2.  Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus.

Authors:  D Gitlin; A Perricelli; G M Gitlin
Journal:  Cancer Res       Date:  1972-05       Impact factor: 12.701

3.  In vitro synthesis of the foetal alpha 1-globulin in man.

Authors:  R Van Furth; M Adinolfi
Journal:  Nature       Date:  1969-06-28       Impact factor: 49.962

4.  Hormonal regulation of alpha1 foetoprotein.

Authors:  L Belanger; D Hamel; L Lachance; D Dufour; M Tremblay; P M Gagnon
Journal:  Nature       Date:  1975-08-21       Impact factor: 49.962

5.  Maintenance of granuloma macrophages in serum-free medium.

Authors:  R M Fauve; H Jusforgues; B Hevin
Journal:  J Immunol Methods       Date:  1983-11-25       Impact factor: 2.303

6.  Localisation of alphafetoprotein (AFP) in murine teratocarcinoma.

Authors:  J Trojan; J Uriel
Journal:  Biomedicine       Date:  1981-12

7.  Characterization, origin and evolution of alpha-fetoprotein and albumin in postnatal rat brain.

Authors:  A Piñeiro; M Calvo; F Iguaz; F Lampreave; J Naval
Journal:  Int J Biochem       Date:  1982

8.  alpha-Fetoprotein-mediated transfer of arachidonic acid into cultured cloned cells derived from a rat rhabdomyosarcoma.

Authors:  J Uriel; J Naval; J Laborda
Journal:  J Biol Chem       Date:  1987-03-15       Impact factor: 5.157

9.  Tissue specificity of alpha-fetoprotein messenger RNA expression during mouse embryogenesis.

Authors:  M A Dziadek; G K Andrews
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  3 in total

1.  Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I.

Authors:  J Trojan; B K Blossey; T R Johnson; S D Rudin; M Tykocinski; J Ilan; J Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes.

Authors:  Y Suzuki; C Q Zeng; E Alpert
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  A systems medicine approach reveals disordered immune system and lipid metabolism in multiple sclerosis patients.

Authors:  M Pazhouhandeh; M-A Sahraian; S D Siadat; A Fateh; F Vaziri; F Tabrizi; F Ajorloo; A K Arshadi; E Fatemi; S Piri Gavgani; F Mahboudi; F Rahimi Jamnani
Journal:  Clin Exp Immunol       Date:  2018-01-25       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.